GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Developments PLC (AQSE:ANA) » Definitions » Notes Receivable

Ananda Developments (AQSE:ANA) Notes Receivable : £0.00 Mil (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Ananda Developments Notes Receivable?

Ananda Developments's Notes Receivable for the quarter that ended in Jul. 2023 was £0.00 Mil.


Ananda Developments Notes Receivable Historical Data

The historical data trend for Ananda Developments's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Developments Notes Receivable Chart

Ananda Developments Annual Data
Trend Jan19 Jan20 Jan21 Jan22 Jan23
Notes Receivable
- - - - -

Ananda Developments Semi-Annual Data
Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Ananda Developments Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Ananda Developments Notes Receivable Related Terms

Thank you for viewing the detailed overview of Ananda Developments's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Ananda Developments (AQSE:ANA) Business Description

Traded in Other Exchanges
Address
60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR
Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Developments (AQSE:ANA) Headlines

No Headlines